Skip to main content
Molecular & Cellular Proteomics : MCP logoLink to Molecular & Cellular Proteomics : MCP
. 2020 Jan;19(1):223. doi: 10.1074/mcp.AAC119.001903

Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.

Mari Masuda, Wei-Yu Chen, Akihiko Miyanaga, Yuka Nakamura, Kumiko Kawasaki, Tomohiro Sakuma, Masaya Ono, Chi-Long Chen, Kazufumi Honda, Tesshi Yamada
PMCID: PMC6944242  PMID: 31894100

VOLUME 13 (2014) PAGES 1429–1438

The total RSK immunoblot in HUH-6 cells in Fig. 3A as well as the total S6K1 immunoblot in JHH1 cells and p-S6K1 immunoblot in JHH-2 cells in Fig. 3C were inadvertently duplicated. These errors have now been corrected and do not affect the results or conclusions of this work. The authors wish to express their sincere apology to the editors and readers of Molecular & Cellular Proteomics for any confusion or inconvenience.

Figure 3A.

Figure 3A.

Figure 3C.

Figure 3C.


Articles from Molecular & Cellular Proteomics : MCP are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES